1. Home
  2. WBX vs LONA Comparison

WBX vs LONA Comparison

Compare WBX & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

N/A

Current Price

$2.76

Market Cap

63.8M

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$5.67

Market Cap

71.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WBX
LONA
Founded
2015
2011
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.8M
71.2M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
WBX
LONA
Price
$2.76
$5.67
Analyst Decision
Hold
Buy
Analyst Count
2
4
Target Price
$4.00
★ $17.33
AVG Volume (30 Days)
12.3K
★ 455.8K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$142.61
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$2.21
52 Week High
$7.60
$14.21

Technical Indicators

Market Signals
Indicator
WBX
LONA
Relative Strength Index (RSI) 42.51 49.07
Support Level $2.64 $4.55
Resistance Level $3.12 $6.13
Average True Range (ATR) 0.15 1.01
MACD 0.00 0.21
Stochastic Oscillator 54.10 77.86

Price Performance

Historical Comparison
WBX
LONA

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments: Europe, the Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: